Shilpa Medicare posted a net loss of Rs 8.1 crore in the March quarter. The pharma firm has reported net losses in three of the four quarters in FY23

Shilpa Medicare tumbles 5% as March quarter performance disappoints

This was the second US FDA inspection of the facility, which tests drugs, raw material and packing materials, within a year

Shilpa Medicare continues to fall despite US FDA relief for Hyderabad unit

The 30-share BSE Sensex climbed 254 points or 0.42 per cent to trade at 60,100, while the broader NSE Nifty moved 77 points or 0.44 per cent higher to trade at 17,701. Mid- and small-cap shares were up as Nifty Midcap 100 rose 0.69 per cent and small-cap gained 0.54 per cent.

Sensex rises over 250 points, Nifty tops 17,700; Shilpa Medicare, Kotak Mahindra Bank & Adani Green jump up to 10%

Shilpa Medicare share price: The stock was last seen trading higher than the 5-day, 20- and 50-day moving averages but lower than the 100-day and 200-day moving averages. The counter’s 14-day relative strength index (RSI) came at 57.82. The company’s stock has a price-to-equity (P/E) ratio of 16.65.…

Shilpa Medicare shares jump 15% today amid heavy volumes; here’s why

The drug is executed from a contract manufacturing site.

Shilpa Medicare shares surge 9% on USFDA final nod to psoriatic arthritis drug

Shilpa Medicare says it will work towards implementing corrective actions to address the FDA observations.

U.S. FDA Flags Two Procedural Lapses At Shilpa Medicare’s Hyderabad Facility

The US Food and Drug Administration (USFDA) conducted good manufacturing practice (GMP) inspection at the company’s analytical services division situated at Unit 7, Nacharam, Hyderabad, Telangana.

Shilpa Medicare Telangana facility gets two USFDA observations

The inspection closed with 2 minor observations, which are related to improvements in existing procedures and are addressable.

Shilpa Medicare’s Analytical Services Division undergoes USFDA inspection

Equitas Small Finance Bank Ltd, Shilpa Medicare Ltd, Polycab India Ltd and Kiri Industries Ltd are among the other losers in the BSE’s ‘A’ group today, 10 March 2023.

GRM Overseas Ltd leads losers in ‘A’ group

Shilpa Medicare Ltd, Privi Speciality Chemicals Ltd, Maharashtra Seamless Ltd and Usha Martin Ltd are among the other gainers in the BSE’s ‘A’ group today, 09 March 2023.

Sequent Scientific Ltd leads gainers in ‘A’ group

Uflex Ltd, Shilpa Medicare Ltd, Dalmia Bharat Sugar & Industries Ltd and Adani Ports & Special Economic Zone Ltd are among the other losers in the BSE’s ‘A’ group today, 22 February 2023.

Adani Enterprises Ltd leads losers in ‘A’ group

Hasn't faired well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Shilpa Medicare Limited is engaged in the business of manufacturing of bulk drugs or active pharmaceutical ingredient (API) and intermediates, and wind power generation.